Evidence map›Paper›PMID 35730400›Full record

ArticleVirulence2022

Biomarkers of caspofungin resistance in

Giuseppe Buda De Cesare, Ahmed Hafez, David Stead, Carlos Llorens, Carol A Munro

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. mBio · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fighting Emerging Caspofungin-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Caspofungin Affects Extracellular Vesicle Production and Cargo inJournal of fungi (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Giuseppe Buda De CesareSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, UK.
Ahmed HafezBiotechvana, Parc Científic Universitat de València, Valencia, Spain.
David SteadAberdeen Proteomics, Rowett Institute ofNutrition and Health, University of Aberdeen, Foresterhill, UK.
Carlos LlorensBiotechvana, Parc Científic Universitat de València, Valencia, Spain.
Carol A MunroSchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, UK.
University of Aberdeen · GBParc Científic de la Universitat de València · ESPompeu Fabra University · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsCandida albicansBiomarkersCaspofunginDrug Resistance, FungalEchinocandinsHumansLipopeptidesMicrobial Sensitivity TestsProteomicsAntifungal AgentsBiomarkersCaspofunginEchinocandinsLipopeptidesCandida albicanscaspofungindrug resistanceinteraction networkproteomics

Identifiers

PMID35730400
PMCPMC9225221
OpenAlexW4283324235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.